Differently, the cytoskeletal protein CFL1 was identified in both benign prostatic hyperplasia and PCa tissues as a histopathological biomarker candidate to avoid the misdiagnosis [78,79]. Here, CFL1 is linked to benign prostatic hyperplasia.